Unknown

Dataset Information

0

Germline SAMD9L truncation variants trigger global translational repression.


ABSTRACT: SAMD9L is an interferon-induced tumor suppressor implicated in a spectrum of multisystem disorders, including risk for myeloid malignancies and immune deficiency. We identified a heterozygous de novo frameshift variant in SAMD9L in an infant with B cell aplasia and clinical autoinflammatory features who died from respiratory failure with chronic rhinovirus infection. Autopsy demonstrated absent bone marrow and peripheral B cells as well as selective loss of Langerhans and Purkinje cells. The frameshift variant led to expression of a truncated protein with interferon treatment. This protein exhibited a gain-of-function phenotype, resulting in interference in global protein synthesis via inhibition of translational elongation. Using a mutational scan, we identified a region within SAMD9L where stop-gain variants trigger a similar translational arrest. SAMD9L variants that globally suppress translation had no effect or increased mRNA transcription. The complex-reported phenotype likely reflects lineage-dominant sensitivities to this translation block. Taken together, our findings indicate that interferon-triggered SAMD9L gain-of-function variants globally suppress translation.

SUBMITTER: Allenspach EJ 

PROVIDER: S-EPMC7970252 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8403910 | biostudies-literature
| S-EPMC2947753 | biostudies-literature
2020-04-13 | GSE148513 | GEO
| S-EPMC7110513 | biostudies-literature
| S-EPMC8857039 | biostudies-literature
2020-04-13 | GSE148512 | GEO
| S-EPMC3004898 | biostudies-other
| S-EPMC2652481 | biostudies-literature
| S-EPMC4053296 | biostudies-literature
| S-EPMC444849 | biostudies-other